Your browser doesn't support javascript.
loading
Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study.
Mitchell, Paul; Sheidow, Tom G; Farah, Michel E; Mahmood, Sajjad; Minnella, Angelo M; Eter, Nicole; Eldem, Bora; Al-Dhibi, Hassan; Macfadden, Wayne; Parikh, Soumil; Dunger-Baldauf, Cornelia; Mahgoub, Mohamed M; Schmidt-Erfurth, Ursula.
Afiliação
  • Mitchell P; Centre for Vision Research, Department of Ophthalmology and Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.
  • Sheidow TG; Ivey Eye Institute, Schulich School of Medicine, Western University, Ontario, Canada.
  • Farah ME; Department of Ophthalmology, Federal University of São Paulo, Paulista School of Medicine, São Paulo, Brazil.
  • Mahmood S; Royal Eye Hospital, Oxford Road, Manchester, United Kingdom.
  • Minnella AM; Institute of Ophthalmology, Catholic University "Sacro Cuore" Foundation "A. Gemelli", Rome, Italy.
  • Eter N; Department of Ophthalmology, University of Muenster Medical Center, Muenster, Germany.
  • Eldem B; Department of Ophthalmology, Hacettepe University, Faculty of Medicine, Sihhiye, Ankara, Turkey.
  • Al-Dhibi H; Vitreoretinal and Uveitis Division, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.
  • Macfadden W; Novartis Pharma AG, Basel, Switzerland.
  • Parikh S; Novartis Pharma AG, Basel, Switzerland.
  • Dunger-Baldauf C; Novartis Pharma AG, Basel, Switzerland.
  • Mahgoub MM; Ain-Shams University, Universidad de El Cairo, Cairo, Egypt.
  • Schmidt-Erfurth U; Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.
PLoS One ; 15(6): e0233595, 2020.
Article em En | MEDLINE | ID: mdl-32492069

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Edema Macular / Inibidores da Angiogênese / Retinopatia Diabética / Ranibizumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Edema Macular / Inibidores da Angiogênese / Retinopatia Diabética / Ranibizumab Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos